Author: Wawrzyniec Dobrucki

Thrilled to share that Dr. Michael Nalappana, has successfully defended his doctoral dissertation! 🎉🎓

Michael’s research — “Evaluating the Receptor for Advanced Glycation End-Products (RAGE) as a Biomarker for Prostate Cancer Diagnosis and Treatment” — represents a meaningful step forward in our understanding of prostate cancer biology. His work explores RAGE as a potential diagnostic and therapeutic biomarker, opening new avenues for earlier detection and more targeted treatment of one of the most prevalent cancers in men worldwide.

When you’re studying a subject as complex as cancer, the most effective approach is often a multifaceted one. Bioengineering professor Wawrzyniec Dobrucki is leading an academically diverse team of researchers on a mission to help prevent and manage prostate cancer through an innovative pairing of biomarker detection and diet, and they are optimistic about the broader impact their research will have.

https://bioengineering.illinois.edu/news/reducing-RAGE-for-better-health

Dr. Pawel Wityk, an assistant professor at Gdansk University of Technology in Gdansk, Poland, has joined the EMIL research group as a visiting researcher. Supported by an international research exchange grant from the Polish National Agency for Academic Exchange (NAWA), Dr. Wityk will spend the next two years investigating the efficacy and mechanisms of protein glycation during X-ray irradiation of cancer in both in vivo and in vitro studies.

Beckman researchers and collaborators received $3 million from the U.S. National Institute on Aging to develop diagnostic tools and imaging agents for the early detection of Alzheimer’s disease. This grant will promote interdisciplinary research and involve both Beckman’s Magnetic Resonance Imaging Laboratory and Molecular Imaging Laboratory.

https://beckman.illinois.edu/about/news/article/2024/02/05/better-together-beckman-imaging-facilities-share-3m-alzheimer-s-research-grant

The Molecular Imaging Laboratory within the Biomedical Imaging Center at the Beckman Institute has acquired a new PET-CT scanner, enabling interdisciplinary research projects through ultra-high spatiotemporal resolution imaging of biological tissues in real-time.

https://beckman.illinois.edu/about/news/article/2024/01/29/beckman-institute-welcomes-new-ultra-high-performance-pet-ct-scanner

The Carle Illinois College of Medicine (CI MED) has announced bioengineering professor Wawrzyniec Dobrucki as the inaugural Neil and Carol Ruzic Faculty Scholar. Dobrucki is a Health Innovation Professor at CI MED and is also the first named professor for the medical school.

Established by Carol Ruzic and her son, David Ruzic, the Neil and Carol Ruzic Carle Illinois College of Medicine Fund honors the vision and spirit of Carol’s late husband and David’s father, Neil Ruzic. The fund will be used to provide support to named faculty appointments for the Carle Illinois College of Medicine, with appointees holding expertise and academic abilities within the field of engineering medicine.

https://bioengineering.illinois.edu/news/Ruzic-Faculty-Scholar